Search Results 1-10 of 16988 for citrulline loading phase

  1. Creatine - Mayo Clinic

    Sarcopenia and bone health. Creatine supplementation might help counteract age-related declines in skeletal muscle and bone mineral density. Heart failure.

  2. A Phase 2/3 Study On The Efficacy And Safety Of Mangaciclanol For ContrastEnhanced MRI Of CNS Or Body In Adult Patients - Mayo Clinic

    The purpose of this study is to identify a dose of mangaciclanol for the Phase 3 part of the study that has an overall diagnostic preference similar to that of ...

  3. A Dose Ranging Phase IIa Study Of 6 Hour Intravenous Dosages Of CXL-1427 In Patients Hospitalized With Heart Failure - Mayo Clinic

    A randomized, double-blinded, placebo-controlled study of continuous 6-hour IV infusions of CXL-1427 in hospitalized patients with systolic heart failure.

  4. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

    Four groups including a placebo group will be enrolled and will receive multiple oral doses of YKP10811 or matching placebo. Participation eligibility.

  5. Hepatocellular carcinoma (HCC) - Stages - Mayo Clinic

    Stage 0 hepatocellular carcinoma means there is one growth of cancer cells, called a tumor, in the liver that is smaller than 2 centimeters (a little more than ...

  6. End-stage renal disease - Doctors and departments - Mayo Clinic

    When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

  7. Nilotinib (oral route) - Side effects & dosage - Mayo Clinic

    It is also given to adults and children with Ph+ CML in chronic phase (CP) or accelerated phase (AP) who have taken other medicines (eg, imatinib, tyrosine- ...

  8. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    During the early phases (phases ... There are also less common very early (phase 0) and later (phase 4) phases. ... citrulline, somatostatin, or analogs thereof ...

  9. Phase ll Study of Pirfenidone in Patients With RAILD - Mayo Clinic

    The purpose of this study is to to assess the safety and tolerability of pirfenidone 2403 mg/day for the treatment of RA-associated interstitial lung disease.

  10. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...